Evidence map›Paper›PMID 22506739›Full record

ArticleAnalytical chemistry2012

Sensitive assay for mycoplasma detection in mammalian cell culture.

M Hannah Degeling, Casey A Maguire, M Sarah S Bovenberg, Bakhos A Tannous

Abstract readEvaluation Study
In one paragraph

Article in Analytical chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Elimination ofFrontiers in cellular and infection microbiology · 2017
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M Hannah DegelingExperimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Department of Neurology, Harvard Medical School, Boston, Massachusetts 02114, USA.
Casey A Maguire
M Sarah S Bovenberg
Bakhos A Tannous

Funding

Interdepartmental Neuroscience CenterP30NS045776 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS, TANNOUS, BAKHOS A · 2003 to 2018
$11.1M
Glioblastoma stem cells therapyR01NS064983 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI TANNOUS, BAKHOS A · 2009 to 2019
$4.0M
Imaging and therapy of tumors using biotinylated cell surface docking sitesR00CA126839 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TANNOUS, BAKHOS A · 2009 to 2011
$732k
NCI NIH HHS 4R00CA126839NCI NIH HHS R00 CA126839NINDS NIH HHS 1R01NS064983NINDS NIH HHS P30 NS045776NINDS NIH HHS P30NS045776NINDS NIH HHS R01 NS064983
6 · The paper itself

Abstract

Mycoplasma contamination in mammalian cell cultures is often overlooked yet is a serious issue which can induce a myriad of cellular changes leading to false interpretation of experimental results. Here, we present a simple and sensitive assay to monitor mycoplasma contamination (mycosensor) based on degradation of the Gaussia luciferase reporter in the conditioned medium of cells. This assay proved to be more sensitive as compared to a commercially available bioluminescent assay in detecting mycoplasma contamination in seven different cell lines. The Gaussia luciferase mycosensor assay provides an easy tool to monitor mammalian cell contaminants in a high-throughput fashion.

Indexed as

AnimalsCell LineCopepodaEnzyme AssaysHumansLuciferasesMycoplasmaMycoplasma InfectionsRecombinant ProteinsSensitivity and SpecificityLuciferasesRecombinant Proteins

Identifiers

PMID22506739
PMCPMC3341502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.